Skip to main content
See every side of every news story
Published • loading... • Updated

BioTissue Introduces Dual-Tab Design for CAM360 AmnioGraft to Improve Clinical Handling

Summary by Eyewire+
Key Takeaways BioTissue has introduced CAM360 AG Dual Tabs to improve handling and preparation of its cryopreserved amniotic membrane therapy The updated product retains the original ringless, hydrated, shelf-stable design and does not require refrigeration The therapy is intended to support ocular surface healing in conditions including dry eye disease, superficial punctate keratitis, and neurotrophic keratitis BioTissue has announced a…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Eyewire+ broke the news on Monday, November 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal